does humana cover glp 1 drugs For all our Medicare folks 👋 — this upcoming GLP-1 Bridge Program may help make select weight-loss medications more affordable starting July 2026. 💉✨ Medicare is about to cover

Description

The glp-1 agonists market is expected to reach US$ 118,926.1 billion by 2032, growing at a significant CAGR of 18.1% from 2026 to 2032.

We pack more into each patch than most brands put in a bottle, and our smooth peel-clear backing makes application effortless every single time

Ahead of the Trump administrations planned expansion of Medicare coverage for GLP-1s to treat obesity through temporary models and the availability of Medicares negotiated price for certain GLP-1 products beginning in 2027, this analysis examines CMSs Medicare Part D claims data from 2019 to 2024 to document the increase in the number of beneficiaries being treated with GLP-1 drugs and the growth in Medicare spending and claims for these drugs.

This analytical review critically examines the evidence surrounding GLP-1 agonists efficacy, safety, and real-world implications for obesity treatment in individuals without diabetes